Publication and interpretation of clinical trial results: The need for caution

Annals of Surgical Oncology

Volumn 19, Issue 6, 2012, Pages 1745-1747

  Thompson, J F ^a,b   Hong, A ^a,b   Fogarty, G ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b MELANOMA INSTITUTE AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BRAIN METASTASIS; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DATA ANALYSIS; HUMAN; INFORMATION DISSEMINATION; MELANOMA; PUBLICATION; REVIEW; STEREOTACTIC RADIOSURGERY; STUDY DESIGN;

CLINICAL TRIALS AS TOPIC; HUMANS; MELANOMA; OUTCOME ASSESSMENT (HEALTH CARE); PUBLICATION BIAS;

EID: 84865114505     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2350-2     Document Type: Review

References (20)

1. Kaplan NM. Recent clinical trials: the good, the bad, and the misleading. Hypertension. 2008;52(4):608-9.
2. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305 (6):569-75.
3. Grady D. Lymph node study shakes pillar of breast cancer care. New York Times. 2011 February 8, 2011.
4. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10 (11):1037-44.
5. Sydes MR, Langley RE. Potential pitfalls in the design and reporting of clinical trials. Lancet Oncol. 2010;11(7):694-700.
6. Cranmer LD, Jeter JM, Morgan SS, Hersh EM, Stea B. Whole-brain radiation therapy in melanoma: an open question. Lancet Oncol. 2010;11(1):13-4.
7. Mahmood U, Kwok Y, Regine WF, Patchell RA. Whole-brain irradiation for patients with brain metastases: still the standard of care. Lancet Oncol. 2010;11(3):221-3.
8. Weiss SE, Kelly PJ. Neurocognitive function after WBRT plus SRS or SRS alone. Lancet Oncol. 2010;11(3):220-1.
9. Randomized trial comparing radiosurgery with vs without whole brain radiotherapy Internet. October 2011; Available at: http://clinicaltrials.gov/ ct2/show/record/NCT00548756. Accessed 21 Nov 2011.
10. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles. JAMA. 2004;291(20):2457-65. (Pubitemid 38669189)
11. Sanghera P, Gardner SL, Scora D, Davey P. Early expansion of the intracranial CSF volume after palliative whole-brain radiotherapy: results of a longitudinal CT segmentation analysis. Int J Radiat Oncol Biol Phys. 2009;76(4):1171-6.
12. Nelson R. Whole-brain radiation increases risk for cognitive decline in patients with brain metastases. Medscape Medical News: Medscape, LLC; 2009.
13. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21): 2483-91. (Pubitemid 43854963)
14. Fogarty G, Morton RL, Vardy J, Nowak AK, Mandel C, Forder PM, et al. Whole brain radiotherapy after local treatment of brain metastases in melanoma patients-a randomised phase III trial. BMC Cancer. 2011;11:142.
15. Bafaloukos D, Gogas H. The treatment of brain metastases in melanoma patients. Cancer Treat Rev. 2004;30(6):515-20. (Pubitemid 39157852)
16. Posner JB. Management of brain metastases. Rev Neurol (Paris). 1992;148(6-7):477-87.
17. Sampson JH, Carter JH Jr, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg. 1998;88(1): 11-20. (Pubitemid 28018958)
18. Fisher B, Seiferheld W, Schultz C, DeAngelis L, Nelson D, Schold SC, et al. Secondary analysis of Radiation Therapy Oncology Group study (RTOG) 9310: an intergroup phase II combined modality treatment of primary central nervous system lymphoma. J Neurooncol. 2005;74(2):201-5. (Pubitemid 41478919)
19. Patchell RA, Tibbs PA, Regine WF, Dempsey RJ, Mohiuddin M, Kryscio RJ, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280(17):1485-9. (Pubitemid 28507400)
20. Henderson MA, Burmeister B, Thompson JF, di Iulio J, Fisher R, Hong A, et al. Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01) abstract LBA9084. J Clin Oncol. 2009;27 (Suppl):18s.